People's Hospital of Xinjiang Uygur Autonomous Region
Phase
Observational
Started
2016-01-01
Last updated
2025-10-06
Condition(s) studied
Cohort StudyNatural PopulationNorthwest Region of China
Study summary
This population-based cohort study on disease prevention and health promotion was established in northwest China, leveraging data from routine annual health examinations. Initiated in January 2016, the cohort enrolled nearly all residents aged 18 years and older who were registered at community healthcare centers. The program was developed to provide a comprehensive framework for disease prevention and community health promotion, with the aim of producing population-based evidence across a broad spectrum of diseases in the general population. At baseline, data were collected on participant demographics, medical and family histories, disability status, living environment, and blood biochemical parameters. Follow-up information is primarily obtained through chronic disease management programs, annual health examinations, and electrical health records. Cause-specific mortality is ascertained from local death registration systems. Biological specimens, questionnaire data, and electrical health records are systematically archived in the Biobank and Big Data Center of the People's Hospital of Xinjiang Uygur Autonomous Region.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
1. Residents \>=18y
2. Permanent residents or individuals who have lived in the region for more than 5 years and are enrolled in local social security medical insurance
3. Residents without severe physical disability and capable of normal communication
4. Residents whose diseases and deaths are monitored and managed by the local health authorities
5. Residents who voluntarily participate and provide written informed consent
Exclusion Criteria:
1. Temporary residents or floating population
2. Residents with severe health conditions that prevent participation in the study
3. Residents who are unwilling to undergo follow-up assessments for the study
Primary outcome measure(s)
Mortality — 20 years All-cause and cause-specific mortality during follow-up
Cardiovascular diseases — 20 years Incident disease during follow-up
Digestive diseases — 20 years Incident disease during follow-up
Endocrine diseases — 20 years Incident disease during follow-up
Infections diseases — 20 years Incident disease during follow-up
Benign neoplasm or Carcinoma in situ — 20 years Incident disease during follow-up
Cancers — 20 years Incident disease during follow-up
Genitourinary diseases — 20 years Incident disease during follow-up
Haematological or immunological diseases — 20 years Incident disease during follow-up
Musculoskeletal diseases — 20 years Incident disease during follow-up
Neurological diseases — 20 years Incident disease during follow-up
Psychiatric diseases — 20 years Incident disease during follow-up
Respiratory diseases — 20 years Incident disease during follow-up
Ocular diseases — 20 years Incident disease during follow-up
Dermatological diseases — 20 years Incident disease during follow-up
Ear and mastoid disorders — 20 years Incident disease during follow-up
Trial sites (1)
Facility
City
Region
Status
People's Hospital of Xinjiang Uygur Autonomous Region
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.